Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration
Part of paid clinical trials in Augusta, Georgia.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05780931
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Age-related Macular Degeneration (AMD)
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Study-specific rehabilitation (SSR) procedures — BEHAVIORALStudy-specific rehabilitation procedures will systematically manipulated the spatial or temporal synchrony (or coordination) of visual vs. haptic inputs that the subjects receive.
Study Details
This study will help develop new methods of rehabilitating Veterans with vision loss due to Age-related macular degeneration.
Key Dates
- Start date
- Mar 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Treatment GroupThis is the group of study subjects which will undergo study-related rehabilitation procedures.
- Arm: Control GroupThis is the group of study subjects which will undergo control (sham) rehabilitation procedures (in addition to all their regularly scheduled treatments and interventions).
Primary Outcome Measure
Accuracy of object recognition [ Time Frame: 6-10 weeks ]
Central Contacts
- Jay Hegde, PhD(706) 733-0188
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Charlie Norwood VA Medical Center, Augusta, GA | Augusta | Georgia | 30904-6258 | Jay Hegde, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Augusta, GA
By research site
Related Studies
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyPHASE3 · Recruiting · Regeneron Pharmaceuticals · Chandler, Arizona
- Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular DegenerationRecruiting · iHealthScreen Inc · Richmond Hill, New York
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsPHASE4 · Enrolling By Invitation · Harrow Inc · Tyler, Texas